BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6204976)

  • 1. Kinetics of association of human proteinases with human alpha 2-macroglobulin.
    Virca GD; Travis J
    J Biol Chem; 1984 Jul; 259(14):8870-4. PubMed ID: 6204976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of alpha 2-macroglobulin with neutrophil and plasma proteinases.
    Salvesen G; Virca GD; Travis J
    Ann N Y Acad Sci; 1983; 421():316-26. PubMed ID: 6202199
    [No Abstract]   [Full Text] [Related]  

  • 3. Human neutrophil elastase and cathepsin G cleavage sites in the bait region of alpha 2-macroglobulin. Proposed structural limits of the bait region.
    Virca GD; Salvesen GS; Travis J
    Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1297-302. PubMed ID: 6195065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase binding and inhibition by the monomeric alpha-macroglobulin rat alpha 1-inhibitor-3.
    Enghild JJ; Salvesen G; Thøgersen IB; Pizzo SV
    J Biol Chem; 1989 Jul; 264(19):11428-35. PubMed ID: 2472396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, function, and control of neutrophil proteinases.
    Travis J
    Am J Med; 1988 Jun; 84(6A):37-42. PubMed ID: 2454577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
    Pratt CW; Tobin RB; Church FC
    J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of human leukocyte elastase, cathepsin G, alpha-2-macroglobulin and alpha-1-proteinase inhibitor in osteoarthrosis and rheumatoid arthritis synovial fluids.
    Virca GD; Mallya RK; Pepys MB; Schnebli HP
    Adv Exp Med Biol; 1984; 167():345-53. PubMed ID: 6201046
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of human neutrophil elastase from alpha 2-macroglobulin complexes containing human neutrophil elastase.
    Stone PJ; Calore JD; Franzblau C
    Ann N Y Acad Sci; 1983; 421():398-400. PubMed ID: 6202211
    [No Abstract]   [Full Text] [Related]  

  • 9. The regulating interrelationship of some serine proteinases from leukocyte with the human plasma kallikrein-kinin system.
    Dotsenko VL; Neshkova EA; Yarovaya GA
    Agents Actions Suppl; 1992; 38 ( Pt 2)():144-56. PubMed ID: 1462823
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
    Goldstein W; Döring G
    Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P; Chignard M
    J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic studies on the interaction of alpha 1-proteinase inhibitor (Pittsburgh) with trypsin-like serine proteinases.
    Travis J; Matheson NR; George PM; Carrell RW
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):853-9. PubMed ID: 3539143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
    Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
    J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of cathepsin G, elastase, and their inhibitors in plasma during methanol intoxication.
    Skrzydlewska E; Szmitkowski M; Farbiszewski R
    J Toxicol Environ Health A; 1999 Jul; 57(6):431-42. PubMed ID: 10478824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis.
    Lundberg E; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1991 Feb; 51(1):23-9. PubMed ID: 1708522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
    Petersen LC; Bjørn SE; Nordfang O
    Thromb Haemost; 1992 May; 67(5):537-41. PubMed ID: 1519213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degradation of human lung elastin by neutrophil proteinases.
    Reilly CF; Travis J
    Biochim Biophys Acta; 1980 Jan; 621(1):147-57. PubMed ID: 6153274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
    Sathe S; Sakata M; Beaton AR; Sack RA
    Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchial leukocyte proteinase inhibitor: hydrodynamic properties and interaction with alpha 2-macroglobulin-bound elastase.
    Stack MS; Smith CE; Dean WL; Johnson DA
    Arch Biochem Biophys; 1988 Jan; 260(1):400-7. PubMed ID: 2449126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-alpha-trypsin inhibitor. Inhibition spectrum of native and derived forms.
    Potempa J; Kwon K; Chawla R; Travis J
    J Biol Chem; 1989 Sep; 264(25):15109-14. PubMed ID: 2475494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.